There is evidence that high expression of SRC is associated with poor clinical outcome, and initial studies showed a role of non-receptor tyrosine kinases of the SRC family (e.g., SFK) in later steps of CRC as well, even if it is not yet well understood how they act in metastasis formation [64]. This evidence concerns the gene SRC and colorectal carcinoma.